Shindo Yuji, Dobashi Yoh, Sakai Toshiyasu, Monma Chie, Miyatani Hiroyuki, Yoshida Yukio
Department of Gastroenterology, Saitama Medical Center, Jichi Medical University Japan.
Department of Pathology, Saitama Medical Center, Jichi Medical University Japan.
Int J Clin Exp Pathol. 2015 Jan 1;8(1):569-77. eCollection 2015.
Although Clostridium perfringens (C. perfringens) is well known as the causative agent of several forms of enteric disease, precise epidemiological and pathobiological aspects are still unknown.
We retrospectively reviewed the culture results of samples collected in our hospital from 2001 through 2013. In addition, for the detection and toxinogenic typing of C. perfringens, polymerase-chain-reaction amplification (PCR)-based rapid analysis was performed in 6 cases using DNA extracted from paraffin-embedded tissues.
A total of 35 samples from 33 cases were positive for C. perfringens, representing an incidence of 0.017% (35/205, 114). Among 33 patients, 21 patients manifested sepsis and 7 patients had bacteremia. One of the septic cases was complicated by fatal intravascular hemolysis and thus, the prevalence was estimated at 3.0% among C. perfringens infections (1/33). The direct causative disease or state for C. perfringens infection was identified in 18 patients: surgery or intervention for cancers, 8 patients; chemotherapy for cancer, 2 patients; surgery or intervention for non-neoplastic disease, 6 patients; liver cirrhosis, 3 patients, etc. PCR-based toxinogenic typing of C. perfringens detected the alpha-toxin gene only in tissue from a patient who died of massive hemolysis; none of the toxin genes could be amplified in the other 5 cases examined.
The prevalence of overt C. perfringens infection is low, but upon detection, infected patients should be carefully monitored for fatal acute hemolysis caused by type A C. perfringens. Furthermore, PCR-based rapid detection of C. perfringens and toxinogenic typing by archival pathological material is applicable as a diagnostic tool.
尽管产气荚膜梭菌是多种肠道疾病的病原体,但确切的流行病学和病理生物学方面仍不清楚。
我们回顾性分析了2001年至2013年我院采集样本的培养结果。此外,为了检测产气荚膜梭菌并进行毒素分型,对6例使用石蜡包埋组织提取的DNA进行基于聚合酶链反应扩增(PCR)的快速分析。
33例患者的35份样本产气荚膜梭菌检测呈阳性,发病率为0.017%(35/205,114)。33例患者中,21例表现为败血症,7例有菌血症。其中1例败血症患者并发致命性血管内溶血,因此产气荚膜梭菌感染中的患病率估计为3.0%(1/33)。18例患者确定了产气荚膜梭菌感染的直接致病疾病或状态:癌症手术或干预,8例;癌症化疗,2例;非肿瘤性疾病手术或干预,6例;肝硬化,3例等。基于PCR的产气荚膜梭菌毒素分型仅在死于大量溶血的患者组织中检测到α毒素基因;在其他5例检测病例中均未扩增出毒素基因。
明显的产气荚膜梭菌感染患病率较低,但一旦检测到,应对感染患者仔细监测由A型产气荚膜梭菌引起的致命性急性溶血。此外,基于PCR的产气荚膜梭菌快速检测和通过存档病理材料进行毒素分型可作为一种诊断工具。